Grove AI’s technology uses voice agents to recruit eligible patients for clinical trials. Formed in 2024, the startup’s rapid ...

Caring for patients with ADHD, or those who potentially have ADHD, extends far beyond diagnosis and prescribing.

What healthcare needs now is a connected, deeply integrated system of action that works with the system of record to complete ...

Rainfall Health, an AI-powered compliance and reimbursement platform for hospitals and medical groups, has raised $15 million in Series A funding, it announced on Wednesday. The San Francisco-based ...

The FTC and the states of Utah and California sued Hims & Hers, alleging it improperly shared consumers’ health information ...

AbbVie is joining the chase for new obesity drugs, but rather than getting a me-too GLP-1 drug, the pharmaceutical giant is landing rights to a clinical-stage molecule that goes after two novel ...

Johnson & Johnson also gains an exclusive option to acquire Sail Biosciences for $2.58 billion. The deal puts J&J in the mix ...

Over the years, Glen Tullman’s disdain for healthcare players like payers, care navigators and benefits consultants has been well documented. Tullman founded Transcarent in 2020 with the notion that ...

A blockbuster Amgen drug for osteoporosis now carries the FDA’s strictest warning that its use can lead to dangerously low levels of calcium in the blood. This complication, hypocalcemia, is a ...

A survey of 112 health system executives finds that Epic's hold on hospital IT keeps getting stronger — but startups still ...

One of the more competitive targets in lung cancer is a certain mutation that has eluded many available targeted therapies. A drug developed by Dizal Pharmaceutical has received FDA approval for ...

With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that offers pipeline-in-a-product ...